Author
Pierre‐Jean Souquet
Also Known As
Pierre-Jean Souquet, Pierre‐Jean Souquet, Pierre‐Jean Souquet,
13
Publications
4.1K
Citations
13
H-Index
24
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 7 | 7 | 3.7K |
2 | Pathology | 5 | 5 | 2.2K |
3 | Immunology | 2 | 2 | 1.4K |
4 | Health Sciences | 1 | 1 | 1.6K |
5 | Cell Biology | 1 | 1 | 47 |
Pierre‐Jean Souquet
×
13
Publications
4.1K
Citations
13
H-Index
| Year | Citations | |
|---|---|---|
2006 | 1.6K | |
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial Naiyer A. Rizvi, Julien Mazières, David Planchard, Checkmate 063Single-arm TrialMedicineImmunologyImmune Checkpoint Inhibitor | 2015 | 1.4K |
2016 | 439 | |
2021 | 253 | |
2002 | 155 | |
2005 | 102 | |
2024 | 47 | |
2017 | 44 | |
2000 | 42 | |
2019 | 23 |
Page 1
Page 1